M&T Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $930K | Sell |
25,816
-3,151
| -11% | -$114K | ﹤0.01% | 868 |
|
|
2025
Q1 | $902K | Buy |
28,967
+5,500
| +23% | +$171K | ﹤0.01% | 857 |
|
|
2024
Q4 | $599K | Buy |
23,467
+4,718
| +25% | +$120K | ﹤0.01% | 1100 |
|
|
2024
Q3 | $531K | Buy |
18,749
+779
| +4% | +$22.1K | ﹤0.01% | 1143 |
|
|
2024
Q2 | $474K | Buy |
17,970
+483
| +3% | +$12.7K | ﹤0.01% | 1132 |
|
|
2024
Q1 | $532K | Sell |
17,487
-1,043
| -6% | -$31.7K | ﹤0.01% | 1125 |
|
|
2023
Q4 | $520K | Buy |
18,530
+2,175
| +13% | +$61.1K | ﹤0.01% | 1117 |
|
|
2023
Q3 | $444K | Buy |
16,355
+1,702
| +12% | +$46.2K | ﹤0.01% | 1135 |
|
|
2023
Q2 | $451K | Buy |
14,653
+423
| +3% | +$13K | ﹤0.01% | 1170 |
|
|
2023
Q1 | $513K | Sell |
14,230
-4,559
| -24% | -$164K | ﹤0.01% | 1101 |
|
|
2022
Q4 | $743K | Buy |
18,789
+8,118
| +76% | +$321K | ﹤0.01% | 958 |
|
|
2022
Q3 | $428K | Buy |
10,671
+259
| +2% | +$10.4K | ﹤0.01% | 1151 |
|
|
2022
Q2 | $437K | Buy |
10,412
+3,119
| +43% | +$131K | ﹤0.01% | 1066 |
|
|
2022
Q1 | $283K | Sell |
7,293
-3,598
| -33% | -$140K | ﹤0.01% | 1224 |
|
|
2021
Q4 | $433K | Buy |
10,891
+23
| +0.2% | +$914 | ﹤0.01% | 1088 |
|
|
2021
Q3 | $393K | Sell |
10,868
-1,923
| -15% | -$69.5K | ﹤0.01% | 1118 |
|
|
2021
Q2 | $524K | Buy |
12,791
+526
| +4% | +$21.5K | ﹤0.01% | 1013 |
|
|
2021
Q1 | $535K | Buy |
12,265
+3,641
| +42% | +$159K | ﹤0.01% | 963 |
|
|
2020
Q4 | $431K | Buy |
+8,624
| New | +$431K | ﹤0.01% | 1134 |
|